Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Cancer Female × Metformin × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 21 Breast Neoplasms 18 Carcinoma, Non-Small-Cell Lung 10 Colorectal Neoplasms 9 Polycystic Ovary Syndrome 7 Lung Neoplasms 7 Pancreatic Neoplasms 6 Endometrial Neoplasms 6 Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 4 Glioblastoma 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4 Rectal Neoplasms 3 Melanoma 3 Leukoplakia, Oral 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Insulin Resistance 2 Hyperandrogenism 2 Esophageal Neoplasms 2 Erythroplasia 2 Carcinoma, Hepatocellular 2 Adenocarcinoma Of Esophagus 2 Weight Gain 1 Urothelial Cancer 1 Triple Negative Breast Neoplasms 1

Interventions

Paclitaxel 2 pyrotinib 1 pembrolizumab 1 palbociclib 1 iniparib 1 darolutamide 1 Thioctic Acid 1 Tamoxifen 1 Pentoxifylline 1 Metformin 1 Doxorubicin 1 Cyclophosphamide 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04170465 2022-09-10

METNEO

Damanhour University

Phase 2 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡